ISSN (Print):
1570-1808
ISSN (Online):
1875-628X

Letters in Drug Design & Discovery

Starting from Volume 22, LDDD will be published by INTERNATIONAL LIFE SCIENCES PUBLISHERS (The journal homepage is under construction)

Impact Factor: 1.2

Indexed in: Scopus, SCI Expanded, JCR... View all

Volume 21 , Issues 19, 2024


Impact Factor
Web of Science Impact Factor

Current: 1.2
5 - Year: 1

Ranking & Category

  • 55th of 59 in Chemistry, Medicinal

Topic(s) Covered

3 Topic(s)

View

Aims & Scope

Letters in Drug Design & Discovery publishes letters, full-length/mini-reviews, research articles, highlights and guest edited thematic issues in all areas of rational drug design and discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. The emphasis is on publishing quality papers very rapidly by taking full advantage of the latest Internet technology for both the submission and review of manuscripts. The journal is an essential reading to all pharmaceutical scientists involved in research in drug design and discovery.

Endorsement(s)

"Letters in Drug Design & Discovery should be available in every library in the pharmaceutical industry and in universities."

R. F. Borne, Associate Director
Laboratory for Applied Drug Design and Synthesis, The University of Mississippi, USA

Archived in
© 2024 Bentham Science Publishers | Privacy Policy